Search Results 2481-2490 of 18286 for rheumatoid arthritis
Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence. Note ...
... factor receptor (EGFR) activating mutations. This study will also assess overall survival, overall response rate, progression free survival assessed by the ...
For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...
Shoulder arthroplasty in patients with juvenile idiopathic arthritis: long-term outcomes. J Shoulder Elbow Surg. 2021 Dec; 30 (12):2703-2710 Epub 2021 July ...
Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary. Mod Pathol ...
Diagnosis of dcSSc according to the 2013 American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) criteria. Must have disease ...
Male or female subjects must be ≥18 years of age. · Subjects must have a diagnosis of SSc as defined by the 2013 American College of Rheumatology criteria/EULAR ...
... factor receptor mutation and PD-L1/PD-L2 expression and literature review. Radiat Oncol. 2018 Sep 5; 13 (1):167 Epub 2018 Sept 05. View PubMed; Swaika A ...
Participation eligibility · Part 1 · Absolute neutrophil count ≥ 1500/μL (≥ 1.5 × 10^9 /L) without growth factor support for 7 days (14 days if on pegfilgrastim); ...
The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.